Free Trial

Zacks Research's Rating of Whitehawk Therapeutics on 8/11/2025

On August 11, 2025, Zacks Research updated its outlook on Whitehawk Therapeutics (NASDAQ:WHWK) with the action "Upgrade", setting a "Strong Sell" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Zacks Research

DateCompanyAction
9/11/2025
SaverOne 2014 Ltd. Sponsored ADR stock logo
SVRE
SaverOne 2014
Upgrade
9/11/2025
Paylocity Holding Corporation stock logo
PCTY
Paylocity
Upgrade
9/11/2025
Quanex Building Products Corporation stock logo
NX
Quanex Building Products
Downgrade
9/11/2025
MediciNova, Inc. stock logo
MNOV
MediciNova
Upgrade
9/11/2025
Karooooo Ltd. stock logo
KARO
Karooooo
Downgrade
9/11/2025
BitFuFu Inc. stock logo
FUFU
BitFuFu
Upgrade
More Ratings From Zacks Research